(Q36425973)

English

Anti-EGFR strategies as an incremental step for the treatment of colorectal cancer patients: moving from scientific evidence to clinical practice.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16548776%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Europe PubMed Central

Anti-EGFR strategies as an incremental step for the treatment of colorectal cancer patients: moving from scientific evidence to clinical practice (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16548776%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

colorectal cancer

1 reference

based on heuristic

inferred from title

Mario Scartozzi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16548776%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Rossana Berardi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16548776%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Stefano Cascinu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16548776%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Chiara Pierantoni

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16548776%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Michela Squadroni

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16548776%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

0 references

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16548776%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Expert Opinion on Therapeutic Targets

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16548776%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16548776%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16548776%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

281-287

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16548776%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.2.281

21 January 2018

Cetuximab: an IgG(1) monoclonal antibody for the treatment of epidermal growth factor receptor-expressing tumours

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.2.281

21 January 2018

Impact of EGFR expression on colorectal cancer patient prognosis and survival

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.2.281

21 January 2018

C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.2.281

21 January 2018

EGFR and cancer prognosis

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.2.281

21 January 2018

EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.2.281

21 January 2018

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.2.281

21 January 2018

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.2.281

21 January 2018

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.2.281

21 January 2018

Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.2.281

21 January 2018

Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): early termination due to increased toxicities

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.2.281

21 January 2018

Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.2.281

21 January 2018

Pharmacological background of EGFR targeting

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.2.281

21 January 2018

Acquired resistance to EGFR inhibitors: mechanisms and prevention strategies

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.2.281

21 January 2018

Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.2.281

21 January 2018

Identifiers

10.1517/14728222.10.2.281

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16548776%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16548776%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36425973&oldid=1518727359"